Abiomed raises revenue outlook, wins US approval for heart pump

(Reuters) - Medical device maker Abiomed Inc raised its full-year revenue forecast and said the U.S. Food and Drug Administration had approved its heart pump, sending its stock up about 30 percent in extended trading.